Delivery Order SPE2DB24D2100-SPE2DB25FBGCS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,250.68 to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml autoinjector on August 29, 2025, with completion expected by September 2, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical delivery to support federal medical procurement needs. The contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a $10,863.60 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of BIMZELX 160 mg/ml autoinjectors. The contract, which will be performed at the company's corporate office location in Conshohocken, Pennsylvania, represents a non-competitive delivery order without set-aside designation. This award is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/mL auto-injectors, a specialty pharmaceutical product, with a ceiling value of $26,727.10. This firm fixed-price delivery order, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive set-aside award. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $45,373.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injectors, with a completion date of July 22, 2025. This non-set-aside contract represents a direct procurement of a specialized pharmaceutical product to support federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $9,783.88 to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml autoinjector on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. The contract represents a single shipment of this specialty...
- The Defense Logistics Agency awarded a delivery order valued at $43,770.93 to AmerisourceBergen Drug Corp for the supply of BIMZELX 320 mg/2 mL auto-injector units. The contract, which was competitively awarded without set-aside restrictions, carries a firm fixed price structure and an ultimate completion date of August 18, 2025. Performance of this delivery order will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,312.33 firm fixed-price delivery order is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product, with a period of performance through July 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,588.45, is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty medication. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIMZELX 320 MG/2 ML AUTOINJECT 2ML medical products, with a ceiling value of $29,565.63 and a performance period ending on July 14, 2025. The contract is not set-aside and was awarded on a firm fixed-price basis. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,912.79 contract is for the delivery of BIMZELX 320 MG/2 ML AUTOINJECT 2ML and is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, allowing the company to provide a wide range of pharmaceutical products...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGCSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of BIMZELX 320 mg/2 mL auto-injector medication with a ceiling value of $64,433.98 under a firm fixed-price contract. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its DLA prime contract vehicle. The SPE2DX IDC functions as a comprehensive global pharmaceutical support mechanism enabling the company to supply an extensive range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This delivery order for BIMZELX, a specialty pharmaceutical product, exemplifies the company's role in fulfilling specialized medical supply requirements across the defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $64.4k | 9/2/25 |